Open Orphan starts trials on nasal spray Covid-19 vaccines

Trials have begun on next-generation vaccine, says Cathal Friel, executive chairman of Irish pharma digital services firm

Cathal Friel of Open Orphan: ‘It is quite controversial, but it will be done under laboratory conditions.’ Picture: Fergal Phillips

Open Orphan has started trials on the next generation of Covid-19 vaccines, according to Cathal Friel, its founder.

The executive chairman and co-founder of the Irish pharmaceutical services company said it had begun phase one trials on a new Covid-19 nasal spray vaccine from US company Codagenix.

The Covi-Vac vaccine comes as a single dose nasal delivery spray and the clinical trial is being conducted by a subsidiary of Open Orphan’s in London called Hvivo.